Research ArticleOncology
Comparison Between 18F-FDG PET–Based and CT-Based Criteria in Non–Small Cell Lung Cancer Patients Treated with Nivolumab
Giovanni Rossi, Matteo Bauckneht, Carlo Genova, Erika Rijavec, Federica Biello, Simone Mennella, Maria Giovanna Dal Bello, Giuseppe Cittadini, Paolo Bruzzi, Roberta Piva, Valentina Ceriani, Gianmario Sambuceti, Egesta Lopci, Silvia Morbelli and Francesco Grossi
Journal of Nuclear Medicine July 2020, 61 (7) 990-998; DOI: https://doi.org/10.2967/jnumed.119.233056
Giovanni Rossi
1Lung Cancer Unit, IRCCS Policlinico San Martino, Genoa, Italy
2Department of Clinical, Surgical, and Experimental Sciences, Division of Experimental Pathology and Oncology, University of Sassari, Sassari, Italy
Matteo Bauckneht
3Nuclear Medicine Unit, IRCCS Policlinico San Martino, Genoa, Italy
Carlo Genova
1Lung Cancer Unit, IRCCS Policlinico San Martino, Genoa, Italy
Erika Rijavec
4Medical Oncology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
Federica Biello
1Lung Cancer Unit, IRCCS Policlinico San Martino, Genoa, Italy
Simone Mennella
5Radiology Unit, IRCCS Policlinico San Martino, Genoa, Italy
Maria Giovanna Dal Bello
1Lung Cancer Unit, IRCCS Policlinico San Martino, Genoa, Italy
Giuseppe Cittadini
5Radiology Unit, IRCCS Policlinico San Martino, Genoa, Italy
Paolo Bruzzi
6Epidemiology Unit, IRCCS Policlinico San Martino, Genoa, Italy
Roberta Piva
3Nuclear Medicine Unit, IRCCS Policlinico San Martino, Genoa, Italy
Valentina Ceriani
3Nuclear Medicine Unit, IRCCS Policlinico San Martino, Genoa, Italy
Gianmario Sambuceti
3Nuclear Medicine Unit, IRCCS Policlinico San Martino, Genoa, Italy
7Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy; and
Egesta Lopci
8Nuclear Medicine Unit, Humanitas Clinical and Research Center–IRCCS, Rozzano, Italy
Silvia Morbelli
3Nuclear Medicine Unit, IRCCS Policlinico San Martino, Genoa, Italy
7Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy; and
Francesco Grossi
4Medical Oncology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
Data supplements
Supplemental Data
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 7
July 1, 2020
Comparison Between 18F-FDG PET–Based and CT-Based Criteria in Non–Small Cell Lung Cancer Patients Treated with Nivolumab
Giovanni Rossi, Matteo Bauckneht, Carlo Genova, Erika Rijavec, Federica Biello, Simone Mennella, Maria Giovanna Dal Bello, Giuseppe Cittadini, Paolo Bruzzi, Roberta Piva, Valentina Ceriani, Gianmario Sambuceti, Egesta Lopci, Silvia Morbelli, Francesco Grossi
Journal of Nuclear Medicine Jul 2020, 61 (7) 990-998; DOI: 10.2967/jnumed.119.233056
Comparison Between 18F-FDG PET–Based and CT-Based Criteria in Non–Small Cell Lung Cancer Patients Treated with Nivolumab
Giovanni Rossi, Matteo Bauckneht, Carlo Genova, Erika Rijavec, Federica Biello, Simone Mennella, Maria Giovanna Dal Bello, Giuseppe Cittadini, Paolo Bruzzi, Roberta Piva, Valentina Ceriani, Gianmario Sambuceti, Egesta Lopci, Silvia Morbelli, Francesco Grossi
Journal of Nuclear Medicine Jul 2020, 61 (7) 990-998; DOI: 10.2967/jnumed.119.233056
Jump to section
Related Articles
Cited By...
- Predictive value of 3'-deoxy-3'-18F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer
- Response Evaluation and Survival Prediction After PD-1 Immunotherapy in Patients with Non-Small Cell Lung Cancer: Comparison of Assessment Methods